title: The Prognostic Role of Angiotensin II Type 1 Receptor Autoantibody in Non-Gravid Hypertension and Pre-eclampsia: A Meta-analysis and Our Studies.
abstract: Angiotensin II type 1 receptor autoantibody (AT1-AA) is found in patients with non-gravid hypertension or pre-eclampsia, but the relationship is uncertain.The aim of the present study was to assess the association between AT1-AA and high blood pressure using meta-analysis, and to evaluate the prognosis value of AT1-AA for hypertensive diseases.Literature search from PubMed, Embase, and Cochrane databases were conducted using keywords "hypertension" or "pre-eclampsia," "angiotensin II receptor type 1 autoantibody," and its aliases from April 1999 to December 2015.Studies evaluating the association between AT1-AA and non-gravid hypertension or pre-eclampsia were included in this analysis. The quality of the eligible studies was assessed based on the Newcastle-Ottawa Scale with some modifications.Two researchers then independently reviewed all included studies and extracted all relevant data. Association between AT1-AA and hypertension was tested with pooled odds ratios (ORs) and 95% confidence intervals (CIs). Finally, we evaluated whether AT1-AA predicted the prognosis of hypertension by using a summary receiver-operating characteristic (ROC) curve and sensitivity analysis.Ten studies were finally included in this meta-analysis. AT1-AA showed more significant association with pre-eclampsia than that with non-gravid hypertension (pooled OR 32.84, 95% CI 17.19-62.74; and pooled OR 4.18, 95% CI 2.20-7.98, respectively). Heterogeneity among studies was also detected probably due to different hypertensive subtypes and AT1-AA measuring methods. Area under summary ROC curve (AUC) of pre-eclampsia was 0.92 (sensitivity 0.76; specificity 0.86). Area under the ROC curve of overall hypertensive diseases or non-gravid hypertension was lower than that of pre-eclampsia (0.86 and 0.72, respectively) with lower sensitivities (0.46 and 0.26, respectively).The major limitation of this analysis was the publication bias due to lack of unpublished data and the language limitation during literature search. Prospective study with large simple size and specific measuring data collection are needed to enhance our findings in the future.Our analysis confirms that elevated AT1-AA in serum is significantly associated with hypertensive disorder, especially pre-eclampsia. AT1-AA may be a valuable indicator for poorer prognosis of patients with pre-eclampsia, and could be used in patients with hypertensive disease for risk evaluation and making individual treatment decision.
authors.affiliation: From the Department of Physiology & Pathophysiology (JL, SZ, YW, PW, HL), School of Basic Medical Sciences, Capital Medical University, Beijing, China; Centers for Metabolic Disease Research (YL), Cardiovascular Research, and Thrombosis Research, Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA; Beijing Key Laboratory of Cardiovascular Diseases and Related Metabolic Dysfunction (JL, SZ, YW, PW, HL), Capital Medical University; and Department of Cardiology (HL), Capital Medical University, Beijing, China.
authors.forename: Jinghui
authors.initials: J
authors.lastname: Lei
authors.forename: Yafeng
authors.initials: Y
authors.lastname: Li
authors.forename: Suli
authors.initials: S
authors.lastname: Zhang
authors.forename: Ye
authors.initials: Y
authors.lastname: Wu
authors.forename: Pengli
authors.initials: P
authors.lastname: Wang
authors.forename: Huirong
authors.initials: H
authors.lastname: Liu
mesh_terms: D001323:Autoantibodies / Q000097:blood*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000175:diagnosis* / Q000276:immunology*; D011225:Pre-Eclampsia / Q000175:diagnosis* / Q000276:immunology*; D011247:Pregnancy; D011379:Prognosis; D017594:Publication Bias; D044140:Receptor, Angiotensin, Type 1 / Q000276:immunology*; D013223:Statistics as Topic
chemical_list: D001323:Autoantibodies; D044140:Receptor, Angiotensin, Type 1